Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
AIM ImmunoTech Inc. See All Filings	D/A	2024-02-21 10:37:33 UTC
Amount To Be Raised $3,301,250 Associated Brokers / Dealers Ascendiant Capital Markets, LLC CIK Number 0000946644 Filed Document 0000946644-24-000002 Exclusions or Exemptions 506b Accepted Date 2024-02-21 10:37:33 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Debt
AIM ImmunoTech Inc. See All Filings	D	2024-02-20 16:34:48 UTC
Amount To Be Raised $3,301,250 Associated Brokers / Dealers Ascendiant Capital Markets, LLC CIK Number 0000946644 Filed Document 0000946644-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-02-20 16:34:48 UTC Type of Offering D Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Debt
HEMISPHERX BIOPHARMA INC See All Filings	D	2018-04-25 16:44:28 UTC
Amount To Be Raised $25,740 Associated Brokers / Dealers Maxim Group LLC CIK Number 0000946644 Filed Document 0001493152-18-005767 Exclusions or Exemptions 506b Accepted Date 2018-04-25 16:44:28 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
HEMISPHERX BIOPHARMA INC See All Filings	D	2017-02-13 14:45:08 UTC
Amount To Be Raised $18,182 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0000946644 Filed Document 0000946644-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-02-13 14:45:08 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
HEMISPHERX BIOPHARMA INC See All Filings	D	2016-09-02 11:39:06 UTC
Amount To Be Raised $33,334 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0000946644 Filed Document 0001609410-16-000004 Exclusions or Exemptions 506b Accepted Date 2016-09-02 11:39:06 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire